Drug profile · INN
carbamazepine
CARNEXIV
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
carbamazepine (CARNEXIV) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12083081
Sterile aqueous choline salt compositions
granted -
US 11344652
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
granted -
US 11311503
Sterile aqueous choline salt compositions
granted -
US 10758642
Sterilization process
granted -
US 10463674
Process for manufacturing sterile ophthalmic pharmaceutical suspensions
granted -
US 10293080
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
granted -
US 8481516
Ciclesonide containing sterile aqueous suspension
granted -
US 7468394
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
granted
Frequently asked questions
What is carbamazepine?
carbamazepine (CARNEXIV) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carbamazepine?
CARNEXIV is a marketed brand name for carbamazepine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carbamazepine?
carbamazepine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.